Expression profiling of SCN8A and NDUFC2 genes in colorectal carcinoma

Experimental Oncology

Volumn 37, Issue 1, 2015, Pages 77-80

  Igci, Y Z ^a   Bozgeyik, E ^a   Borazan, E ^a   Pala, E ^e   Suner, A ^b   Ulasli, M ^a   Gurses, S A ^c   Yumrutas, O ^d   Balik, A A ^a   Igci, M ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b Adiyaman Training and Research Hospital   (Turkey)

^c ZIRVE UNIVERSITY   (Turkey)

^d ADIYAMAN UNIVERSITY   (Turkey)

^e SANKO UNIVERSITY   (Turkey)

Author keywords

Colorectal carcinoma; Complex I; Gene expression; NDUFC2; SCN8A; Voltage gated sodium channels

Indexed keywords

MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TRANSCRIPTOME; VOLTAGE GATED SODIUM CHANNEL; NDUFC2 PROTEIN, HUMAN; SCN8A PROTEIN, HUMAN; SODIUM CHANNEL NAV1.6;

ADULT; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER TISSUE; COLORECTAL CANCER CELL LINE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENDER; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NDUFC2 GENE; ONCOGENE; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; SCN8A GENE; TUMOR LOCALIZATION; AGED; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED;

AGED; COLORECTAL NEOPLASMS; ELECTRON TRANSPORT COMPLEX I; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NAV1.6 VOLTAGE-GATED SODIUM CHANNEL; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84927664197     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: 10.31768/2312-8852.2015.37(1):77-80     Document Type: Article

References (21)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
2. Pardini B, Naccarati A, Vodicka P, et al. Gene expression variations: potentialities of master regulator polymorphisms in colorectal cancer risk. Mutagenesis 2012; 27: 161-7.
3. Geyik E, Igci YZ, Pala E, et al. Investigation of the association between ATP2B4 and ATP5B genes with colorectal cancer. Gene 2014; 540: 178-82.
4. Prevarskaya N, Skryma R, Shuba Y. Ion channels and the hallmarks of cancer. Trends Mol Med 2010; 16: 107-21.
5. O'Brien JE, Meisler MH. Sodium channel SCN8A (Nav1.6): properties and de novo mutations in epileptic encephalopathy and intellectual disability. Front Genet 2013; 4: 213.
6. Fraser SP, Pardo LA. Ion channels: functional expression and therapeutic potential in cancer. Colloquium on Ion Channels and Cancer. EMBO Rep 2008; 9: 512-5.
7. Gao R, Shen Y, Cai J, et al. Expression of voltage-gated sodium channel alpha subunit in human ovarian cancer. Oncol Rep 2010; 23: 1293-9.
8. House CD, Vaske CJ, Schwartz AM, et al. Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion. Cancer Res 2010; 70: 6957-67.
9. Hernandez-Plata E, Ortiz CS, Marquina-Castillo B, et al. Overexpression of NaV 1.6 channels is associated with the invasion capacity of human cervical cancer. Int J Cancer 2012; 130: 2013-23.
10. Shan B, Dong M, Tang H, et al. Voltage-gated sodium channels were differentially expressed in human normal prostate, benign prostatic hyperplasia and prostate cancer cells. Oncol Lett 2014; 8: 345-50.
11. Loeffen J, van den Heuvel L, Smeets R, et al. cDNA sequence and chromosomal localization of the remaining three human nuclear encoded iron sulphur protein (IP) subunits of complex I: the human IP fraction is completed. Biochem Biophys Res Commun 1998; 247: 751-8.
12. Chomova M, Racay P. Mitochondrial complex I in the network of known and unknown facts. Gen Physiol Biophys 2010; 29: 3-11.
13. Janssen RJ, Nijtmans LG, van den Heuvel LP, et al. Mitochondrial complex I: structure, function and pathology. J Inherit Metab Dis 2006; 29: 499-515.
14. Woerner SM, Kloor M, Mueller A, et al. Microsatellite instability of selective target genes in HNPCC-associated colon adenomas. Oncogene 2005; 24: 2525-35.
15. Chin SF, Teschendorff AE, Marioni JC, et al. High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol 2007; 8: R215.
16. Igci YZ, Arslan A, Akarsu E, et al. Differential expression of a set of genes in follicular and classic variants of papillary thyroid carcinoma. Endocr Pathol 2011; 22: 86-96.
17. Santidrian AF, Matsuno-Yagi A, Ritland M, et al. Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. J Clin Invest 2013; 123: 1068-81.
18. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8.
19. Sideris M, Papagrigoriadis S. Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer. Anticancer Res 2014; 34: 2061-8.
20. Diss JK, Stewart D, Pani F, et al. A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo. Prostate Cancer Prostatic Dis 2005; 8: 266-73.
21. Brackenbury WJ, Chioni AM, Diss JK, et al. The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat 2007; 101: 149-60.